Puma Biotechnology, Inc.
Puma Biotechnology, Inc. (PBYI) Stock Overview
Explore Puma Biotechnology, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
154.4M
P/E Ratio
4.08
EPS (TTM)
$0.78
ROE
0.49%
PBYI Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Puma Biotechnology, Inc. (PBYI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 33.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.36.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4.08 and a market capitalization of 154.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.